ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 0.1.63 (23 May 2017) - 2999001/02516420CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120181017W173deBibliographieenBibliographyfrBibliographieEP10799037.6201012222012062120160104enenen0938230220091223EP307579 P20100224US2018101720184220121031201244201808222018342018040920181017201842C07D 401/14 20060101AFI20110714BHEP C07D 403/04 20060101ALI20110714BHEP C07D 403/14 20060101ALI20110714BHEP C07D 409/14 20060101ALI20110714BHEP A61K 31/506 20060101ALI20110714BHEP A61P 29/00 20060101ALI20110714BHEP A61P 37/08 20060101ALI20110714BHEP deAMINOALKYLPYRIMIDIN-DERIVATE ALS HISTAMIN-H4-REZEPTOR-ANTAGONISTENenAMINOALKYLPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTSfrDÉRIVÉS D'AMINOALKYLPYRIMIDINE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR H4 DE L'HISTAMINEEP-A- 1 505 064WO-A-2004/039796WO-A-2009/068512WO-A-2009/080721WO-A1-2006/110763COWART M D ET AL: "Rotationally Constrained 2,4-Diamino-5,6-disubstituted Pyrimidines: A New Class of Histamine H4 Receptor Antagonists with Improved Druglikeness and in Vivo Efficacy in Pain and Inflammation Models", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 51, 26 September 2008 (2008-09-26), pages 6547-6557, XP002543231, ISSN: 0022-2623 [retrieved on 2008-09-26]CARCELLER GONZÁLEZ, ElenaJoan Miró 2E-08190 Sant Cugat del VallèsESVIRGILI BERNADO, MarinaPlaza Lesseps 11E-08023 BarcelonaESSOLIVA SOLIVA, RobertFrederica Montseny 42-44 5° 4ªE-08980 Sant Feliu de LlobregatESFERRER COSTA, CarlesIndústria 84-86 2° 2ªE-08370 CalellaESMedicis Pharmaceutical Corporation101764231156 645 aa/sis400 Somerset Corporate Blvd.Bridgewater, NJ 08807USHoffmann Eitle100061036Patent- und Rechtsanwälte PartmbB Arabellastraße 3081925 MünchenDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTREP201007056220101222enWO201107687820110630201126